Current Computer-Aided Drug Design

Author(s): Jun Chang*, Shaoqing Zou, Subo Xu, Yiwen Xiao and Du Zhu*

DOI: 10.2174/1573409919666230417080832

DownloadDownload PDF Flyer Cite As
Screening of Inhibitors against Idiopathic Pulmonary Fibrosis: Few-shot Machine Learning and Molecule Docking based Drug Repurposing

Page: [134 - 144] Pages: 11

  • * (Excluding Mailing and Handling)

Abstract

Introduction: Idiopathic pulmonary fibrosis is a chronic progressive disorder and is diagnosed as post-COVID fibrosis. Idiopathic pulmonary fibrosis has no effective treatment because of the low therapeutic effects and side effects of currently available drugs.

Aim: The aim is to screen new inhibitors against idiopathic pulmonary fibrosis from traditional Chinese medicines.

Methods: Few-shot-based machine learning and molecule docking were used to predict the potential activities of candidates and calculate the ligand-receptor interactions. In vitro A549 cell model was taken to verify the effects of the selected leads on idiopathic pulmonary fibrosis.

Results: A logistic regression classifier model with an accuracy of 0.82 was built and, combined with molecule docking, used to predict the activities of candidates. 6 leads were finally screened out and 5 of them were in vitro experimentally verified as effective inhibitors against idiopathic pulmonary fibrosis.

Conclusion: Herbacetin, morusin, swertiamarin, vicenin-2, and vitexin were active inhibitors against idiopathic pulmonary fibrosis. Swertiamarin exhibited the highest anti-idiopathic pulmonary fibrosis effect and should be further in vivo investigated for its activity.

Keywords: Few-shot machine learning, molecule docking, virtual screen, idiopathic pulmonary fibrosis, drug repurposing, traditional chinese medicines.

Graphical Abstract